Skip to main content
. 2018 Oct 13;35(11):2093–2102. doi: 10.1007/s12325-018-0803-0

Table 3.

Mean medications over time: all eyes and low- and high-IOP subgroups

All eyes (n = 53) Baseline IOP ≤ 23 mmHg (n = 28) Baseline IOP > 23 mmHg (n = 25)
Mean medication (n) ± SEa Mean difference (n) Medication change (%) Mean medication (n) ± SE Mean difference (n) Medication change (%) Mean medication (n) ± SE Mean difference (n) Medication change (%)
Baseline (n = 53) 2.5 (0.2) 2.5 (0.2) 2.6 (0.3)
Day 1 (n = 53) 1.7 (0.2) − 0.8 − 32.0 1.6 (0.3) − 0.9 − 36.0 1.9 (0.3) − 0.7 − 26.9
Week 1 (n = 51) 1.8 (0.2) − 0.7 − 28.0 1.7 (0.3) − 0.8 − 32.0 1.9 (0.3) − 0.7 − 26.9
Month 1 (n = 52) 1.8 (0.2) − 0.7 − 28.0 1.7 (0.3) − 0.8 − 32.0 2.0 (0.3) − 0.6 − 23.1
Month 3 (n = 43) 1.5 (0.2) − 1.0 − 40.0 1.4 (0.3) − 1.1 − 44.0 1.5 (0.3) − 1.1 − 42.3
Month 6 (n = 53) 1.5 (0.2) − 1.0 − 40.0 1.6 (0.3) − 0.9 − 36.0 1.3 (0.3) − 1.3 − 50.0

aReported are least squares means and associated standard errors from a mixed model for repeated measure analysis. Per Bonferroni pairwise comparison, the difference from baseline in mean medications is statistically significant at each follow-up visit (p < 0.05) except for month 1 (p = 0.100)